Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
JSPR
JSPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JSPR News
Jasper Appoints Jeet Mahal as CEO, Focuses on Chronic Urticaria Treatment
Jan 07 2026
Globenewswire
Jasper Stock Soars Following Positive Results from New Asthma Study
Dec 02 2025
Benzinga
Jasper Reports Positive ETESIAN Study Data for Briquilimab, 180mg Dose Shows Significant Asthma Improvement
Dec 02 2025
Globenewswire
Jasper Reports Positive ETESIAN Study Data for Briquilimab, 180mg Dose Shows Significant Asthma Improvement
Dec 02 2025
Newsfilter
Jasper Therapeutics Announces Encouraging Findings for Briquilimab in Phase 1b Study of Allergic Asthma
Dec 02 2025
NASDAQ.COM
Jasper Therapeutics to Hold Webinar Showcasing Results from BEACON and ETESIAN Studies
Dec 02 2025
NASDAQ.COM
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Jasper Therapeutics to Host Webinar Presenting briquilimab Study Findings
Dec 01 2025
Newsfilter
Bragar Eagel & Squire Investigates Officers and Directors of Driven Brands and Jasper Therapeutics for Long-Term Stockholders, Urging Investors to Reach Out to the Firm
Nov 22 2025
Globenewswire
IMPORTANT NOTICE for NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Notifies Investors About Class Action Lawsuits for Shareholders
Nov 18 2025
Globenewswire
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces Opportunity for Jasper Therapeutics, Inc. Investors Facing Significant Losses to Initiate Class Action Lawsuit
Nov 18 2025
Globenewswire
Bragar Eagel & Squire, P.C. Alerts Jasper, KBR, Spirit, and Molina Stockholders About Approaching Deadlines and Encourages Investors to Reach Out to the Firm
Nov 17 2025
Globenewswire
JSPR DEADLINE: ROSEN, A TOP INVESTOR LAW FIRM, Urges Jasper Therapeutics, Inc. Shareholders to Obtain Legal Representation Ahead of Key November 18 Deadline in Securities Class Action – JSPR
Nov 16 2025
Globenewswire
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR
Nov 14 2025
PRnewswire
IMPORTANT NOTICE for NX, JSPR, KBR, RICK: Law Offices of Howard G. Smith Notify Shareholders About Chance to Head Securities Fraud Class Actions
Nov 14 2025
Globenewswire
Jasper Therapeutics, Inc. Faces Lawsuit for Securities Law Breaches - Reach Out to DJS Law Group to Understand Your Rights – JSPR
Nov 14 2025
Globenewswire
Show More News
